Lupus Science & Medicine

Age-related patterns of organ damage impact on health-related quality of life in SLE

Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...
Lupus Science & Medicine

Association between disease duration and comorbidity burden in systemic lupus erythematosus: a multicentre study from Pakistan

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...
lupus.bmj

Combining mepacrine with hydroxychloroquine-based therapy in active systemic lupus erythematosus: an observational study of 106 patients from the Lupus-Cruces cohort

Objective To evaluate the efficacy of mepacrine (MC) as an add-on therapy in patients with SLE unresponsive to hydroxychloroquine (HCQ)-containing regimens at 6 months after MC introduction. Methods ...
lupus.bmj

LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients

Background Belimumab and low dose IL2 (Ld-IL2) has been identified effective in the treatment of systemic lupus erythematosus (SLE). However, the application of combined therapy for SLE has not been ...
Lupus Science & Medicine

Burden of herpes zoster among patients with systemic lupus erythematosus in the USA

Objective To estimate the incidence of herpes zoster (HZ) and the incremental healthcare resource utilisation (HRU) and costs ...
lupus.bmj

Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature review

Objective Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological diagnosis that can be associated with SLE. The clinical presentation, risk factors and outcomes of PRES in ...